FDA Inspection
Reproductive Medicine InstituteReproductive Medicine Institute – FDA Inspection, Jun 9, 2026
Record Details
This FDA Inspection record concerns Reproductive Medicine Institute, with an inspection on June 9, 2026, issued by the Chicago District Office, covering biologics.
View Company Profile
ID · cad92f77-b2be-448c-9168-4f11ca6dfe8f
Inspection Facts
- Inspection number
- 1321232
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.90(c)Eligibility not required--warning labels
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Reproductive Medicine Institute
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 19, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 12, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 19, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 29, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Reproductive Medicine Institute
- FDA Inspection 1216427 - 2023-08-21
- FDA Inspection 1057831 - 2018-06-19
- FDA Inspection 969650 - 2016-05-12
- FDA Inspection 879502 - 2014-05-19
- FDA Inspection 754960 - 2011-11-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.